GC15511
LIMKi 3
Also known as N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)pyrazol-5-yl]-1,3-thiazol-2-yl]-2-methylpropanamide
LIMKi 3 (LIMKi 3) is a potent LIMK inhibitor with IC50s of 7 nM and 8 nM for LIMK1 and LIMK2, respectively
ChemicalCAS1338247-35-0MW431.29FormulaC17H14Cl2F2N4OS
- CAS number
- 1338247-35-0
- Molecular weight
- 431.29
- Formula
- C17H14Cl2F2N4OS
- Solubility
- DMF： 15 mg/ml,DMSO： 25 mg/ml,DMSO：PBS (pH 7·2)(1：5)： 0·2 mg/ml,Ethanol： 1 mg/ml
- InChIKey
- IVUGBSGLHRJSSP-UHFFFAOYSA-N
- Catalogue number
- GC15511
- Brand
- GLPBIO
Computed properties PubChem CID 56965901 · XLogP 5.1 · TPSA 88.1 Ų · H-bond donors 1
- XLogP
- 5.1
- TPSA
- 88.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 27
SMILES CC(C)C(=O)NC1=NC=C(S1)C2=CC(=NN2C3=C(C=CC=C3Cl)Cl)C(F)F
Computed descriptors from PubChem (CID 56965901), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il